Innovation

5 patent families (1 granted) — focus: Human necessities; filing pace dormant. Cited 95 times.

Investor mix

10 investors on record; lead investors include New Enterprise Associates, EW Healthcare Partners; 1 has since exited.

Investor type	Count	Share
Venture capital	7	70%
Private equity	2	20%
Other / undisclosed	1	10%